中华中医药学刊

山慈菇在乳腺疾病中的应用及机制研究进展

PDF下载

任园园 ¹ , 刘胜 ²

中华中医药学刊 | 国家项目点击 2026,44(9): 146-151

收起

中华中医药学刊 |国家项目点击 2026 , 44 (9) : 146 -151

山慈菇在乳腺疾病中的应用及机制研究进展

全屏

[Author(id=1319291262625230998, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1319291261505351820, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1319291262709117080, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1319291261505351820, authorId=1319291262625230998, language=EN, stringName=Yuanyuan REN, firstName=Yuanyuan, middleName=null, lastName=REN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=¹, address=^1.Jiangxi University of Chinese Medicine, Nanchang 330004, Jiangxi, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1319291262772031641, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1319291261505351820, authorId=1319291262625230998, language=CN, stringName=任园园, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=¹, address=^1.江西中医药大学，江西　南昌　330004, bio={"content":"

任园园（1994-），女，山西临汾人，博士在读，研究方向：中医药防治乳腺疾病。

"}, bioImg=null, bioContent=

任园园（1994-），女，山西临汾人，博士在读，研究方向：中医药防治乳腺疾病。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1319291262264520847, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1319291261505351820, xref=1., ext=[AuthorCompanyExt(id=1319291262272909456, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1319291261505351820, companyId=1319291262264520847, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=^1.Jiangxi University of Chinese Medicine, Nanchang 330004, Jiangxi, China), AuthorCompanyExt(id=1319291262277103761, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1319291261505351820, companyId=1319291262264520847, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=^1.江西中医药大学，江西　南昌　330004)])]), Author(id=1319291262834946203, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1319291261505351820, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=lshtcm@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1319291262918832285, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1319291261505351820, authorId=1319291262834946203, language=EN, stringName=Sheng LIU, firstName=Sheng, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=², address=^2.Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1319291262994329758, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1319291261505351820, authorId=1319291262834946203, language=CN, stringName=刘胜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=², address=^2.上海中医药大学附属龙华医院，上海　200032, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1319291262340018322, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1319291261505351820, xref=2., ext=[AuthorCompanyExt(id=1319291262348406931, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1319291261505351820, companyId=1319291262340018322, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=^2.Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China), AuthorCompanyExt(id=1319291262352601236, tenantId=1146029695717560320, journalId=1255847919539208197, articleId=1319291261505351820, companyId=1319291262340018322, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=^2.上海中医药大学附属龙华医院，上海　200032)])])]

任园园¹, 刘胜²

作者信息

^1.江西中医药大学，江西　南昌　330004

^2.上海中医药大学附属龙华医院，上海　200032

通讯作者:

刘胜（1968-），男，上海人，教授、主任医师，博士研究生导师，博士，研究方向：中医药防治乳腺疾病。E-mail：lshtcm@163.com。

作者简介:

任园园（1994-），女，山西临汾人，博士在读，研究方向：中医药防治乳腺疾病。

Advances in Application and Mechanism of Shancigu (Cremastrae Pseudobulbus Pleiones Pseudobulbus) in Breast Diseases

Yuanyuan REN¹, Sheng LIU²

Affiliations

^1.Jiangxi University of Chinese Medicine, Nanchang 330004, Jiangxi, China

^2.Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China

出版时间: 2026-09-10 doi: 10.13193/j.issn.1673-7717.2026.09.028

文章导航

摘要

收起

乳腺疾病作为女性常见疾病，严重影响女性身体及心理健康，且发病率持续攀升。当前西药治疗存在耐药性、激素紊乱及复发等问题，中医药在调节机体整体平衡及多靶点联合干预等方面具有独特优势，且不良反应较少。山慈菇作为一种兰科植物，其性凉，味甘、微辛，归于肝脾二经，具有清热解毒、散结消肿之效，早在《本草纲目》中便有“主痈肿疮瘘，瘰疬结核”的记载，故其在乳腺疾病的中医治疗中应用广泛。通过对以往山慈菇治疗乳腺炎、乳腺增生、乳腺癌的临床应用及作用机制进行归纳分析，并进一步提出山慈菇“炎-增生-癌变”三级联防治体系的假说，为今后的研究提供新思路及理论支撑，以便更好地发挥山慈菇在乳腺疾病中的应用价值。

关键词

山慈菇 / 乳腺炎 / 乳腺增生 / 乳腺癌 / 临床应用 / 作用机制

Abstract

收起

As a common female disease, breast disease seriously affects women's physical and psychological health, and the incidence rate is on the rise. Current Western medicine treatments face issues such as drug resistance, hormonal imbalances and recurrence. Traditional Chinese medicine, on the other hand, possesses unique advantages in regulating the body's overall balance and multi-target combined intervention, with relatively fewer adverse effects. As an orchid plant with cool nature, Shancigu (Cremastrae Pseudobulbus Pleiones Pseudobulbus) is sweet and slightly pungent, attributed to the liver and spleen meridians and has the functions of clearing heat and reliving toxin, dissipating mass and eliminating swelling. As early as in Compendium of Materia Medica, it was recorded that “Shancigu (Cremastrae Pseudobulbus Pleiones Pseudobulbus) mainly treats carbuncles, abscesses, fistulas and tuberculosis”. Therefore, it is widely used in the traditional Chinese medical treatment of breast diseases. This paper summarized and analyzed the clinical application and mechanism of action of Shancigu (Cremastrae Pseudobulbus Pleiones Pseudobulbus) in the treatment of mastitis, mammary gland hyperplasia and breast cancer, and further proposed the hypothesis of “inflammation-proliferation-carcinoma” tertiary prevention and control system of Shancigu (Cremastrae Pseudobulbus Pleiones Pseudobulbus) in order to provide new ideas and theoretical support for future research, so as to better utilize the value of Shancigu (Cremastrae Pseudobulbus Pleiones Pseudobulbus) in the application of mammary gland diseases.

Key words

Shancigu (Cremastrae Pseudobulbus Pleiones Pseudobulbus) / mastitis / mammary gland hyperplasia / breast cancer / clinical application / mechanism

引用本文

任园园, 刘胜. 山慈菇在乳腺疾病中的应用及机制研究进展. 中华中医药学刊, 2026 , 44 (9) : 146 -151 . DOI: 10.13193/j.issn.1673-7717.2026.09.028

Yuanyuan REN, Sheng LIU. Advances in Application and Mechanism of Shancigu (Cremastrae Pseudobulbus Pleiones Pseudobulbus) in Breast Diseases[J]. Chinese Archives of Traditional Chinese Medicine, 2026 , 44 (9) : 146 -151 . DOI: 10.13193/j.issn.1673-7717.2026.09.028

基金

收起

国家自然科学基金面上项目(82474508)

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

[1]

SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.

[2]

宫文晔, 洪陈彦, 钟钰婷, 等. 非哺乳期乳腺炎临床特征及诊疗研究进展[J]. 解放军医学杂志, 2023, 48(12): 1478-1485.

[3]

BURGUIN A, DIORIO C, DUROCHER F. Breast cancer treatments: updates and new challenges[J]. J Pers Med, 2021, 11(8): 808.

[4]

管庆霞, 杨寒, 刘宇萌, 等. 中药复方联合外用疗法治疗乳腺增生的研究进展[J]. 中国中药杂志, 2023, 48(11): 2856-2867.

[5]

邢政, 游雄斌, 沃立科, 等. 中医药治疗非哺乳期乳腺炎的研究进展[J]. 长春中医药大学学报, 2025, 41(2): 210-215.

[6]

王泽鹏, 程旭锋, 张文可, 等. 中医药治疗激素受体阳性乳腺癌的研究进展[J]. 环球中医药, 2025, 18(1): 174-181.

[7]

国家药典委员会. 中华人民共和国药典: 一部[S]. 北京: 中国医药科技出版社, 2020: 34.

[8]

陈诗, 赵玥, 王振, 等. 山慈菇药理作用及临床应用研究进展[J]. 中华中医药学刊, 2023, 41(6): 247-250.

[9]

AMIR L H. Academy of breastfeeding medicine protocol committee. ABM clinical protocol #4: mastitis, revised March 2014[J]. Breastfeed Med, 2014, 9(5): 239-243.

[10]

DELGADO S, ARROYO R, MARTÍN R, et al. PCR-DGGE assessment of the bacterial diversity of breast milk in women with lactational infectious mastitis[J]. BMC Infect Dis, 2008, 8: 51.

[11]

MONTAGUE E C, HILINSKI J, ANDRESEN D, et al. Evaluation and treatment of mastitis in infants[J]. Pediatr Infect Dis J, 2013, 32(11): 1295-1296.

[12]

GoULABCHAND R, HAFIDI A, VAN DE PERRE P, et al. Mastitis in autoimmune diseases: review of the literature, diagnostic pathway, and pathophysiological key players[J]. J Clin Med, 2020, 9(4): 958.

[13]

ZHOU F, SHANG X C, TIAN X S, et al. Clinical practice guidelines for diagnosis and treatment of patients with non-puerperal mastitis: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021[J]. Chin Med J, 2021, 134(15): 1765-1767.

[14]

袁江山, 程旭锋, 徐留燕, 等. 荆防温消方治疗肉芽肿性小叶性乳腺炎肿块期阴证[J/OL]. 中医学报, 2024: 1-11. (2024-08-06). https://kns.cnki.net/KCMS/detail/detail.aspx?filename=HNZK2024080200M&dbname=CJFD&dbcode=CJFQ.

[15]

牛莹超, 兴伟, 任伊宁, 等. 疏肝化浊方联合微波理疗治疗浆细胞性乳腺炎肝经蕴热证的临床观察[J]. 中医药导报, 2024, 30(7): 86-90.

[16]

高路明, 步玉辉, 韩晓琳, 等. 乳腺肿疼冷敷凝胶膏外敷治疗哺乳期乳腺炎疗效观察[J]. 现代中西医结合杂志, 2023, 32(4): 526-529.

[17]

王爽, 张亚英, 李亚珍, 等. 乳腺疏导推拿配合中药外敷治疗哺乳期急性乳腺炎的疗效观察[J]. 中国妇幼保健, 2018, 33(6): 1216-1218.

[18]

UCIECHOWSKI P, DEMPKE W C M. Interleukin-6: a masterplayer in the cytokine network[J]. Oncology, 2020, 98(3): 131-137.

[19]

HIRANO T. IL-6 in inflammation, autoimmunity and cancer[J]. Int Immunol, 2021, 33(3): 127-148.

[20]

REN K, TORRES R. Role of interleukin-1β during pain and inflammation[J]. Brain Res Rev, 2009, 60(1): 57-64.

[21]

HARDING D, FANTI S, MARELLI-BERG F. Tumour necrosis factor-α in cardiac inflammation: friend or foe?[J]. Cardiovasc Res, 2024, 120(1): 1-2.

[22]

MARNELL L, MOLD C, DU CLOS T W. C-reactive protein: ligands, receptors and role in inflammation[J]. Clin Immunol, 2005, 117(2): 104-111.

[23]

刘颖, 马丽杰, 董欣敏, 等. 山慈菇正丁醇提取物对NR8383细胞分泌的IL-1β和TNF-α水平的影响[J]. 科学技术与工程, 2019, 19(24): 93-97.

[24]

宋银辉, 包和义, 王敬琪, 等. 基于JNK1/AP-1信号通路探究山慈菇提取液对乳腺癌大鼠的干预效果[J]. 中国老年学杂志, 2024, 44(14): 3536-3540.

[25]

程银水. 栽培山慈菇的化学成分及抗炎活性研究[D]. 十堰: 湖北医药学院, 2024.

[26]

阮小丽, 施大文. 山慈菇的抗肿瘤及抑菌作用[J]. 中药材, 2009, 32(12): 1886-1888.

[27]

黄小容. 山慈菇水层部分抗菌活性筛选和分离纯化研究[D]. 贵阳: 贵州大学, 2009.

[28]

李琦, 陈宇纵, 辛海量. 山慈菇的化学成分及药理作用研究进展[J]. 药学实践杂志, 2014, 32(4): 250-253, 260.

[29]

JUSTIZ VAILLANT A A, JAMAL Z, PATEL P, et al. Immunoglobulin. In: StatPearls[M]. Treasure Island (FL): StatPearls Publishing, 2023.

[30]

DINARELLO C A. Immunological and inflammatory functions of the interleukin-1family[J]. Annu Rev Immunol, 2009, 27: 519-550.

[31]

RIAZ RAJOKA M S, SHI J L, ZHU J, et al. Capacity of lactic acid bacteria in immunity enhancement and cancer prevention[J]. Appl Microbiol Biotechnol, 2017, 101(1): 35-45.

[32]

姜爽, 徐婧瑶, 苏鑫, 等. 山慈菇多糖的免疫调节作用及对小鼠骨肉瘤细胞S180体内生长抑制作用[J]. 食品科学, 2018, 39(13): 216-221.

[33]

吴小南, 杨雪帆, 朱萍萍, 等. 慈菇多糖对免疫功能低下小鼠免疫调节作用[J]. 中国公共卫生, 2015, 31(1): 73-75.

[34]

杨雪帆. 慈菇多糖对小鼠免疫功能及mTOR信号通路的影响[D]. 福州: 福建医科大学, 2015.

[35]

刘胜, 王怡, 吴春宇, 等. 中西医结合临床诊疗乳腺增生专家共识[J]. 中华中医药杂志, 2023, 38(3): 1159-1164.

[36]

SWEETLAND H M. Benign disorders and diseases of the breast[M]. London: Bailliere Tindal, 2009: 1-4.

[37]

QIAO N, WANG Q N, TAO Y, et al. α-Cyperone ameliorates depression in mammary gland hyperplasia and chronic unpredictable mild stress rat by regulating hormone, inflammation, and oxidative stress[J]. Immunopharmacol Immunotoxicol, 2023, 45(1): 73-82.

[38]

DANFORTH D N. Molecular profile of atypical hyperplasia of the breast[J]. Breast Cancer Res Treat, 2018, 167(1): 9-29.

[39]

JOHN E M, KOO J, PHIPPS A I, et al. Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer E-tiology in Minorities study[J]. Breast Cancer Res, 2024, 26(1): 88.

[40]

贾颖, 王友球. 逍遥蒌贝胶囊对乳腺增生患者激素水平的干预作用[J]. 世界中西医结合杂志, 2018, 13(6): 820-823.

[41]

肖平. 乳核散结片治疗乳腺增生病4257例[J]. 世界中医药, 2010, 5(2): 109.

[42]

王剑平. 乳宁颗粒联合中药药渣外敷法在乳腺增生病中的临床研究[J]. 辽宁中医杂志, 2022, 49(10): 74-76.

[43]

闻艳华. 行气散结方穴位敷贴配合针灸疗法治疗乳腺增生(瘀痰互结型)疗效观察[J]. 四川中医, 2019, 37(7): 204-207.

[44]

余望贻, 姜海斌, 于萍, 等. 乳腺增生I号对兔乳腺增生病模型影响的实验研究[J]. 湖南中医学院学报, 2003, 23(3): 10-12.

[45]

JIANG M Y, LIANG Y C, PEI Z L, et al. Diagnosis of breast hyperplasia and evaluation of RuXian-I based on metabolomics deep belief networks[J]. Int J Mol Sci, 2019, 20(11): 2620.

[46]

林妮, 邱玉文, 何贡云, 等. 荔枝核皂苷对大鼠乳腺增生的作用及对雌激素信号通路的影响[J]. 中药材, 2015, 38(4): 798-802.

[47]

姜雨飞, 王世鄂. 雌激素受体ERα与PI3K/AKT细胞信号通路[J]. 解剖学研究, 2012, 34(2): 142-145.

[48]

WEN P S, LI J, WEN Z H, et al. MICAL-L2, as an estrogen-responsive gene, is involved in ER-positive breast cancer cell progression and tamoxifen sensitivity via the AKT/mTOR pathway[J]. Biochem Pharmacol, 2024, 225: 116256.

[49]

兴伟, 刘远, 徐曌, 等. 山慈菇通过PI₃K/AKT信号通路影响乳腺癌MDA-MB-231细胞的增殖和凋亡[J]. 中国免疫学杂志, 2020, 36(6): 693-698, 706.

[50]

李军梅, 刘建勋, 邢泽田, 等. 乳结消颗粒对家兔乳腺增生的影响[J]. 中华中医药杂志, 2020, 35(9): 4626-4630.

[51]

连小龙, 赵敏, 韩宇, 等. 西黄丸对乳腺增生大鼠抗氧化能力、乳腺组织雌激素受体和孕激素受体表达的影响[J]. 中药药理与临床, 2017, 33(5): 9-12.

[52]

MENSE S M, REMOTTI F, BHAN A, et al. Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure[J]. Toxicol Appl Pharmacol, 2008, 232(1): 78-85.

[53]

李军梅, 刘建勋, 邢泽田, 等. 乳结消颗粒对肝郁气滞型乳腺增生模型大鼠的影响[J]. 中药新药与临床药理, 2020, 31(6): 627-636.

[54]

VILCHIS-LANDEROS M M, VÁZQUEZ-MEZA H, VÁZQUEZ-CARRADA M, et al. Antioxidant enzymes and their potential use in breast cancer treatment[J]. Int J Mol Sci, 2024, 25(11): 5675.

[55]

孟海波. 山慈菇多糖的抗氧化及降脂作用研究[D]. 长沙: 湖南农业大学, 2015.

[56]

房宇坤, 宁安红, 刘磊, 等. 山慈菇多糖的提取及其抗氧化作用的研究[J]. 大连医科大学学报, 2017, 39(6): 527-531.

[57]

孟军华, 安靖, 王雄, 等. 回乳抑增一号对乳腺增生大鼠激素受体及细胞增殖、凋亡的影响[J]. 中成药, 2021, 43(6): 1457-1461.

[58]

MÜLLER R, MISUND K, HOLIEN T, et al. Targeting proliferating cell nuclear antigen and its protein interactions induces apoptosis in multiple myeloma cells[J]. PLoS One, 2013, 8(7): e70430.

[59]

CARPENTER R, BRADY M F. BAX Gene. In: StatPearls[M]. Treasure Island (FL): StatPearls Publishing, 2023.

[60]

李芮, 薛东华, 商雪纯, 等. 解毒胶囊对乳腺增生大鼠PCNA和BcL-2表达影响[J]. 辽宁中医药大学学报, 2018, 20(5): 23-26.

[61]

于林楠, 翟宏颖. 山慈菇提取物对结肠癌HT29细胞凋亡的影响[J]. 中国民族民间医药, 2016, 25(16): 17-19.

[62]

VIALE G, GIOBBIE-HURDER A, REGAN M M, et al. Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole[J]. J Clin Oncol, 2008, 26(34): 5569-5575.

[63]

SHAN B, LI W, YANG S Y, et al. Estrogen up-regulates MMP2/9 expression in endometrial epithelial cell via VEGF-ERK1/2 pathway[J]. Asian Pac J Trop Med, 2013, 6(10): 826-830.

[64]

ZHANG X, BI C L, SHI H C, et al. Structural studies of a mannoglucan from Cremastra appendiculata (Orchidaceae) by chemical and enzymatic methods[J]. Carbohydr Polym, 2021, 272: 118524.

[65]

李余先, 杜刚, 官丽丽, 等. 山慈菇提取物抑制血管形成的药效学研究[J]. 吉林农业, 2015(21): 76-77.

[66]

SHIM J S, KIM J H, LEE J, et al. Anti-angiogenic activity of a homoisoflavanone from Cremastra appendiculata[J]. Planta Med, 2004, 70(2): 171-173.

[67]

KIM J H, KIM K H, KIM J H, et al. Homoisoflavanone inhibits retinal neovascularization through cell cycle arrest with decrease of cdc2 expression[J]. Biochem Biophys Res Commun, 2007, 362(4): 848-852.

[68]

LI Q R, XIA C F, LI H, et al. Disparities in 36 cancers across 185 countries: secondary analysis of global cancer statistics[J]. Front Med, 2024, 18(5): 911-920.

[69]

QI J L, LI M L, WANG L J, et al. National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data[J]. Lancet Public Health, 2023, 8(12): e943-e955.

[70]

GAO X K, ZHU L H, LU X, et al. KIF15 contributes to cell proliferation and migration in breast cancer[J]. Hum Cell, 2020, 33(4): 1218-1228.

[71]

FAN L, STRASSER-WEIPPL K, LI J J, et al. Breast cancer in China[J]. Lancet Oncol, 2014, 15(7): e279-e289.

[72]

温晓梨, 蔡芳燕, 程碧婷, 等. 中医药防治乳腺癌的药理作用机制研究进展[J]. 中国实验方剂学杂志, 2025, 31(22): 252-263.

[73]

罗楚凡. 蒌慈散结方干预三阴性乳腺癌复发转移的回顾性队列研究[D]. 北京: 北京中医药大学, 2020.

[74]

陈建华. 孙桂芝教授病证结合治疗乳腺癌经验整理与临床研究[D]. 北京: 中国中医科学院, 2012.

[75]

田华琴, 王艳杰, 王斌, 等. 乳积方加减对激素受体阴性乳腺癌术后复发转移的影响[J]. 中国中西医结合杂志, 2017, 37(2): 169-173.

[76]

陈芳. 解毒散结方辅助治疗乳腺癌放化疗后31例临床观察[J]. 中国民族民间医药, 2021, 30(2): 106-108.

[77]

陈红, 杨永, 孟慧, 等. 化痰散结治疗乳腺癌的研究概况[J]. 环球中医药, 2019, 12(1): 145-148.

[78]

刘颖, 张子英, 马丽杰. 山慈菇抗乳腺癌的作用机制研究进展[J]. 现代药物与临床, 2019, 34(3): 863-866.

[79]

吴灵君, 梁聪, 黄菊, 等. 复方山慈菇对人乳腺癌MDA-MB-231细胞裸鼠移植瘤生长的抑制作用及网络药理学分析[J]. 中国癌症防治杂志, 2023, 15(3): 298-303.

[80]

杨婷婷, 李志远, 孙小慧, 等. 基于网络药理学探讨山慈菇治疗乳腺癌的作用机制[J]. 西部中医药, 2022, 35(12): 44-49.

[81]

曹晓东, 张楠, 杨冬冬, 等. 定量蛋白质组学筛选及分析山慈菇酯提物抗4T1乳腺癌的新启示[J]. 天然产物研究与开发, 2021, 33(2): 246-255.

[82]

HAJISHENGALLIS G, NETEA M G, CHAVAKIS T. Trained immunity in chronic inflammatory diseases and cancer[J]. Nat Rev Immunol, 2025, 25(7): 497-514.

[83]

刘颖, 刘艳秋, 李翠玲, 等. 抑制NLRP3炎症小体中Caspase-1活化对大鼠颈动脉球囊损伤后内膜增生的保护作用[J]. 中山大学学报(医学科学版), 2017, 38(2): 250-253.

2026年第44卷第9期

PDF下载

引用本文

BibTeX

文章信息

doi: 10.13193/j.issn.1673-7717.2026.09.028

首发时间：2026-10-20
出版时间：2026-09-10

补充材料

相关文章

文章信息

作者

出版历史

基金

国家自然科学基金面上项目(82474508)

作者信息

^1.江西中医药大学，江西　南昌　330004

^2.上海中医药大学附属龙华医院，上海　200032

通讯作者:

刘胜（1968-），男，上海人，教授、主任医师，博士研究生导师，博士，研究方向：中医药防治乳腺疾病。E-mail：lshtcm@163.com。

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zhzyyxk/CN/10.13193/j.issn.1673-7717.2026.09.028

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT